Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.

Song, Chengyang; Shang, Fangjian; Tu, Wei; Liu, Xiaodan

Song, Chengyang; Shang, Fangjian; Tu, Wei; Liu, Xiaodan.

Afiliação

Song C; Department of Thoracic and Cardiovascular Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang, China.
Shang F; Department of General Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang, China.
Tu W; Department of General Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang, China.
Liu X; Department of General Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang, China. lxdan728@sina.com.

BMC Cancer ; 23(1): 296, 2023 Mar 31.

Article em En | MEDLINE | ID: mdl-37004015

Assuntos

Neoplasias da Mama; Neoplasias Renais; Humanos; Feminino; Neoplasias da Mama/genética; Prognóstico; Fosfatidilinositol 3-Quinases; Oncogenes; Microambiente Tumoral; Proteínas do Tecido Nervoso

Palavras-chave

Breast cancer; DIP2B; Her-2 positive; Immune microenvironment; Immunosuppression; Immunotherapy; Oncogene; Pancancer; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google